Figure S1. GPER stimulation triggers FAK Y397 activation in SUM159 TNBC cells. Immunoblots showing FAK phosphorylation in SUM159 cells treated for 30 min with 100 nM E2 (A) or 100 nM G1 (B) alone or in combination with 100 nM GPER antagonist G-15. Side panels show densitometric analysis of the immunoblots normalized to the loading control. Immunoblots showing FAK phosphorylation in SUM159 cells treated for 30 min with 100 nM E2 (C) or 100 nM G1 (D) alone and in combination with 1 μM FAK kinase inhibitor VS-4718. Side panels show densitometric analysis of the immunoblots normalized to the loading control. FAK expression was used as loading control for pFAK. Results shown are representative of at least three independent experiments. (*) indic...
Lapatinib treatment significantly reduces viability of SK-BR-3âsensitive but not SK-BR-3 lapatinib...
Alterations in mitogen-activated protein kinase (MAPK) signaling following treatment of breast cance...
Figure S1. IC50 values for the anti-proliferative effect of RAD001 and neratinib in relation to the ...
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S4. The GPER antagonist G-15 and the FAK inhibitor VS-4718 inhibit the migration of SUM159 TN...
Figure S3. The GPER antagonist G-15 reduces the migration of MDA-MB 231 TNBC cells induced by E2 and...
Figure S1. The PI3K/AKT pathway significantly contributes to the ligand-driven HER2 signaling activi...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. Representative photos of TG2-overexpressing MCF7 cells (MCF7_TG2) and control vector-tran...
Figure S6: (A) Percentage of sub-G1 population identified using propidium iodide staining and quanti...
Figure S3. Collagen signaling stimulates the malignant phenotype of ovarian cancer cells. (TIFF 3512...
FC-IBC02 cell proliferation assays: estimated time trends in response to different CEP-37440 concent...
Figure S1. RTK expression and ERBB2-targeting antibody response in breast cancer cell lines. Figure ...
Figure S4. Genetic suppression of GSK3β expression decreases the sphere-forming potential of mesench...
Table S1. Detailed information of antibodies used in the study. Table S2. Clinicopathologic characte...
Lapatinib treatment significantly reduces viability of SK-BR-3âsensitive but not SK-BR-3 lapatinib...
Alterations in mitogen-activated protein kinase (MAPK) signaling following treatment of breast cance...
Figure S1. IC50 values for the anti-proliferative effect of RAD001 and neratinib in relation to the ...
Figure S2. The MEK inhibitor PD98059 and the PI3K inhibitor Wortmannin prevent respectively the acti...
Figure S4. The GPER antagonist G-15 and the FAK inhibitor VS-4718 inhibit the migration of SUM159 TN...
Figure S3. The GPER antagonist G-15 reduces the migration of MDA-MB 231 TNBC cells induced by E2 and...
Figure S1. The PI3K/AKT pathway significantly contributes to the ligand-driven HER2 signaling activi...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Figure S1. Representative photos of TG2-overexpressing MCF7 cells (MCF7_TG2) and control vector-tran...
Figure S6: (A) Percentage of sub-G1 population identified using propidium iodide staining and quanti...
Figure S3. Collagen signaling stimulates the malignant phenotype of ovarian cancer cells. (TIFF 3512...
FC-IBC02 cell proliferation assays: estimated time trends in response to different CEP-37440 concent...
Figure S1. RTK expression and ERBB2-targeting antibody response in breast cancer cell lines. Figure ...
Figure S4. Genetic suppression of GSK3β expression decreases the sphere-forming potential of mesench...
Table S1. Detailed information of antibodies used in the study. Table S2. Clinicopathologic characte...
Lapatinib treatment significantly reduces viability of SK-BR-3âsensitive but not SK-BR-3 lapatinib...
Alterations in mitogen-activated protein kinase (MAPK) signaling following treatment of breast cance...
Figure S1. IC50 values for the anti-proliferative effect of RAD001 and neratinib in relation to the ...